CTRI/2023/05/053303尚未招募Unknown
Epidural versus PEricapsular Nerve Group block as perioperative analgesia model on persistent post-operative hip pain following hip Surgery: Retrospective evaluation.
AIIMS Raipur0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •All patients who underwent total hip replacement (THR) during the period of January-December 2022
排除标准
- •Any patientâ??s whose data cannot be collected, including but not limited to- loss to follow-up, discharged in less than 48 hours, not willing to answer the questionnaire, incapacitated, expired
研究者
相似试验
进行中（未招募）
不适用
A randomized, placebo-controlled, 2-arm parallel-group, multicenter study with a 24-week double-blind treatment period assessing the efficacy and safety of lixisenatide in patients with Type 2 diabetes insufficiently controlled with insulin glargine and metformin - GETGOAL DUO 1Type II DiabetesMedDRA version: 11.1Level: LLTClassification code 10045242Term: <Manually entered code. Term in E.1.1>EUCTR2008-007335-40-NLSanofi-Aventis Recherche & Développement950
进行中（未招募）
不适用
A randomized, placebo-controlled, 2-arm parallel-group, multicenter study with a 24-week double-blind treatment period assessing the efficacy and safety of lixisenatide in patients with Type 2 diabetes insufficiently controlled with insulin glargine and metformin - GETGOAL DUO 1Type II DiabetesMedDRA version: 11.1Level: LLTClassification code 10045242Term: <Manually entered code. Term in E.1.1>EUCTR2008-007335-40-SESanofi-Aventis Recherche & Développement950
进行中（未招募）
不适用
A randomized, placebo-controlled, 2-arm parallel-group, multicenter study with a 24-week double-blind treatment period assessing the efficacy and safety of lixisenatide in patients with Type 2 diabetes insufficiently controlled with insulin glargine and metformin - GETGOAL DUO 1Type II DiabetesMedDRA version: 11.1Level: LLTClassification code 10045242Term: <Manually entered code. Term in E.1.1>EUCTR2008-007335-40-PLSanofi-Aventis Recherche & Développement950
进行中（未招募）
不适用
A randomized, placebo-controlled, 2-arm parallel-group, multicenter study with a 24-week double-blind treatment period assessing the efficacy and safety of lixisenatide in patients with Type 2 diabetes insufficiently controlled with insulin glargine and metformin - GETGOAL DUO 1EUCTR2008-007335-40-CZSanofi-Aventis Recherche & Développement950
进行中（未招募）
1 期
A randomized, placebo-controlled, 2-arm parallel-group, multicenter study with a 24-week double-blind treatment period assessing the efficacy and safety of lixisenatide in patients with Type 2 diabetes insufficiently controlled with insulin glargine and metformiType II DiabetesMedDRA version: 11.1Level: LLTClassification code 10045242Term: <Manually entered code. Term in E.1.1>EUCTR2008-007335-40-GRSanofi-Aventis Recherche & Développement750